 Assessment response cancer therapy positron emission tomography order usefulness PET assessment therapeutic effects FDG-PET studies therapy patients miscellaneous malignant tumors change FDG uptake therapy change tumor size prognosis lesions high FDG uptake therapy lesions low FDG uptake therapy change increase tumor size therapy decreased FDG uptake therapy prominent partial response group change group FDG uptake therapy non-relapse group relapse group decreased FDG uptake good prognosis patient change tumor size decreased FDG uptake recurrence FDG-PET complementary role assessment therapeutic effects